Yeasts as probiotics: Mechanisms, outcomes, and future potential
| Autor: | Thomas J. Mansell, Swastik Sen |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0303 health sciences
biology 030306 microbiology Probiotics Saccharomyces cerevisiae Computational biology biology.organism_classification Microbiology Genome Yeast Genome engineering law.invention Saccharomyces boulardii Saccharomyces 03 medical and health sciences Probiotic law Yeasts Genetics Animals Humans Gene Function (biology) 030304 developmental biology |
| Zdroj: | Fungal Genetics and Biology. 137:103333 |
| ISSN: | 1087-1845 |
| DOI: | 10.1016/j.fgb.2020.103333 |
| Popis: | The presence of commensal fungal species in the human gut indicates that organisms from this kingdom have the potential to benefit the host as well. Saccharomyces boulardii, a yeast strain isolated about a hundred years ago, is the most well-characterized probiotic yeast. Though for the most part it genetically resembles Saccharomyces cerevisiae, specific phenotypic differences make it better suited for the gut microenvironment such as better acid and heat tolerance. Several studies using animal hosts suggest that S. boulardii can be used as a biotherapeutic in humans. Clinical trials indicate that it can alleviate symptoms from gastrointestinal (GI) tract infections to some extent, but further trials are needed to understand the full therapeutic potential of S. boulardii. Improvement on probiotic function using engineered yeast is an attractive future direction, though genome modification tools for use in S. boulardii have been limited until recently. However, some tools available for S. cerevisiae should be applicable for S. boulardii as well. In this review, we summarize the observed probiotic effect of this yeast and the state of the art for genome engineering tools that could help enhance its probiotic properties. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect